INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![ai-data-GettyImages-2236890597]( "Don't Just Swap The Engine. Redesign The Factory.")
Don't Just Swap The Engine. Redesign The Factory.Discover how AI-native technology is accelerating study startup, streamlining operations, and helping sponsors and CROs deliver therapies to patients faster.
-
![ai-clinical-trials-tech]( "Aligning Global Standards For ICH E6(R3) And Artificial Intelligence")
Aligning Global Standards For ICH E6(R3) And Artificial IntelligenceGlobal standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.
-
![GettyImages-2153183419-digital-signature-eConsent]( "Streamlining Trials With eConsent And EDC")
Streamlining Trials With eConsent And EDCIntegrating eConsent with EDC streamlines clinical workflows, improves data accuracy, and enhances patient engagement by creating a unified, compliant system for consent and trial data management.
-
![AI, artificial intelligence in healthcare-GettyImages-2187633236]( "Empower Your Trial With Data And Evidence")
Empower Your Trial With Data And EvidenceFuel your clinical development and decision-making with insights from fit-for-purpose data and evidence.
-
Navigating The Enrollment Bottleneck In Early Oncology Trials1/12/2026
Slow oncology trial enrollment raises costs and delays progress. AI prescreening, patient-focused engagement, and early pharmacology studies help accelerate recruitment and optimize trial design.
-
Outgrowing Excel: Implementing RTSM Software In A Live Phase I Trial3/26/2026
Moving from manual spreadsheets to RTSM mid-study requires precision. Learn how clinical teams maintain trial momentum while executing protocol changes without delays.
-
Navigating The Evolving Regulatory And Data Landscape8/19/2024
Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.
-
Creating A New World In Clinical Trial Feasibility Utilizing Advanced Analytics11/26/2024
Citeline utilizes several data resources to enhance feasibility strategies and help clients drive patient engagement and recruitment.
-
The Scoop On The SCOPE Summit2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![GettyImages-966826582 data, research, analytics]( "Drive Patient Enrollments With Data-Powered Recruitment Engine")
Generate consistent, successful clinical trial recruitment on repeat with Citeline Connect's multifaceted approach to patient engagement and recruitment.
-
![Quality control assurance satisfaction-GettyImages-2117357383]( "Ergomed's Risk-Based Quality Management")
Ergomed’s Meticulous Risk-Based Quality Management Approach
As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.
-
![Telemedicine In Dermatology Success]( "Driving Success In Dermatology Drug Development")
Our dedicated teams are led by in-house, board-certified dermatologists who have decades of experience conducting early and late phase studies. Download the available datasheet to learn more.
-
![GettyImages-1135573728-digital-patient-tablet-recruitment]( "Enhance Clinical Trial Screening And Improve Patient Matching Accuracy")
Bridge the gap between raw data and clinical enrollment. Use AI-driven insights and natural language summaries to identify the right patients faster and with greater transparency.
-
![GettyImages-675233504 doctor tablet]( "PPD Monitoring Application (MApp): A Flexible Technical Solution")
This dynamic, system-agnostic approach to modernizing clinical trial monitoring supports targeted oversight, as well as sampling at the subject, visit, and form levels.
